Bell Investment Advisors, Inc Acadia Pharmaceuticals Inc Transaction History
Bell Investment Advisors, Inc
- $542 Million
- Q3 2024
A detailed history of Bell Investment Advisors, Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 63 shares of ACAD stock, worth $1,062. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63Holding current value
$1,062% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding ACAD
# of Institutions
279Shares Held
156MCall Options Held
901KPut Options Held
314K-
Baker Bros. Advisors LP New York, NY42.9MShares$723 Million7.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.8MShares$234 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$231 Million3.36% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$203 Million0.0% of portfolio
-
State Street Corp Boston, MA5.97MShares$101 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.73B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...